Drugs / Nitrafurozon
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT04277182 | Sep 2020 | — | Izmir Katip Celebi University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Nitrafurozon | “0.2% Nitrafurozon will be applied topically for 21 days.” NCT04277182 ↗ |
| Route | Topical | “applied topically for 21 days” NCT04277182 ↗ |